Jeon Sohee, Oh Il-Hoan
Catholic High-Performance Cell Therapy Center & Department of Medical Lifescience; Department of Ophthalmology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 137-701, Korea.
Catholic High-Performance Cell Therapy Center & Department of Medical Lifescience, The Catholic University of Korea, Seoul 137-701, Korea.
BMB Rep. 2015 Apr;48(4):193-9. doi: 10.5483/bmbrep.2015.48.4.276.
Degenerative retinal diseases affect millions of people worldwide, which can lead to the loss of vision. However, therapeutic approaches that can reverse this process are limited. Recent efforts have allowed the possibility of the stem cell-based regeneration of retinal cells and repair of injured retinal tissues. Although the direct differentiation of pluripotent stem cells into terminally differentiated photoreceptor cells comprises one approach, a series of studies revealed the intrinsic regenerative potential of the retina using endogenous retinal stem cells. Muller glial cells, ciliary pigment epithelial cells, and retinal pigment epithelial cells are candidates for such retinal stem cells that can differentiate into multiple types of retinal cells and be integrated into injured or developing retina. In this review, we explore our current understanding of the cellular identity of these candidate retinal stem cells and their therapeutic potential for cell therapy against degenerative retinal diseases.
退行性视网膜疾病影响着全球数百万人,可导致视力丧失。然而,能够逆转这一过程的治疗方法有限。最近的研究使得基于干细胞的视网膜细胞再生和受损视网膜组织修复成为可能。虽然将多能干细胞直接分化为终末分化的光感受器细胞是一种方法,但一系列研究揭示了利用内源性视网膜干细胞的视网膜内在再生潜力。穆勒胶质细胞、睫状色素上皮细胞和视网膜色素上皮细胞是这类视网膜干细胞的候选者,它们可以分化为多种类型的视网膜细胞,并整合到受损或发育中的视网膜中。在这篇综述中,我们探讨了目前对这些候选视网膜干细胞的细胞特性及其针对退行性视网膜疾病进行细胞治疗的潜力的理解。